SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC - ORIC PHARMACEUTICALS INC ownership

ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 83 filers reported holding ORIC PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC ownership history of ORIC PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$73,000
-81.3%
13,643
-48.6%
0.00%
-90.0%
Q4 2021$390,000
-12.8%
26,543
+24.0%
0.01%
+25.0%
Q3 2021$447,00021,3990.01%
Other shareholders
ORIC PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 602,272$2,698,0008.92%
Column Group LLC 3,568,181$15,985,0003.40%
Euclidean Capital LLC 747,550$3,349,0002.85%
Invus Financial Advisors, LLC 1,007,575$4,514,0002.72%
SILVERARC CAPITAL MANAGEMENT, LLC 1,082,304$4,849,0001.49%
Monaco Asset Management SAM 364,741$1,634,0000.71%
EcoR1 Capital, LLC 3,418,068$15,313,0000.53%
DAFNA Capital Management LLC 415,926$1,863,0000.51%
Boxer Capital, LLC 1,054,000$4,722,0000.30%
Casdin Capital, LLC 601,515$2,695,0000.23%
View complete list of ORIC PHARMACEUTICALS INC shareholders